Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-27

Clinical Trial Update: Nitazoxanide in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nitazoxanide for ulcerative colitis is currently recruiting at Alexandria University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Alexandria University | Conditions: Ulcerative Colitis | Phase 2 | Status: RECRUITING